CV
TECX

Clarus Ventures’s Tectonic Therapeutic TECX Stock Holding History

Clarus Ventures’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$154M Hold
246,860
– – 36.11% 1
2018
Q2 		$84.6M Buy
+246,860
New +$89.1M 30.09% 1

Other funds holding TECX

SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Clarus Ventures's TECX Position: Q3 2018 in Review

Clarus Ventures held its Tectonic Therapeutic (TECX) position steady in Q3 2018 at 246,860 shares worth $154M. The position accounts for 36.11% of the portfolio, ranked #1.

Clarus Ventures first reported a position in TECX in Q2 2018 and has held it in 2 quarters since. 63 funds tracked by Wall St. Rank hold TECX as of Q3 2018.

  • Clarus Ventures held 246,860 shares of Tectonic Therapeutic worth $154M as of Q3 2018.
  • Clarus Ventures left its Tectonic Therapeutic share count unchanged in Q3 2018.
  • Tectonic Therapeutic made up 36.11% of Clarus Ventures's portfolio in Q3 2018, its #1 holding.
  • Clarus Ventures first reported a position in Tectonic Therapeutic in Q2 2018 and has held it in 2 quarters since.
  • 63 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q3 2018.

Based on Clarus Ventures's 13F filing for Q3 2018, filed 14 Nov 2018.